Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Question about long form

"leading to about $8M net to PTSC."

That would be a 2 cent dividend and a one time 17% return (based in today's close) which would certainly put the SP back on an "up and to the left" trajectory, especially if more dividends are to follow.

Still, as been noted in the past, without some identifiable measure of institutional investment, this stock will continue to experience turbulence.

Hopefully the BoD will deliver on the dividends that were hinted at and will not try to get clever with other investments...

GLTA

Share
New Message
Please login to post a reply